[1]李 军,王 淼,李 伟,等.重组人脑利钠肽对急性心力衰竭早期肾损伤的疗效研究[J].医学信息,2018,31(11):73-75.[doi:10.3969/j.issn.1006-1959.2018.11.023]
　LI Jun,WANG Miao,LI Wei,et al.Therapeutic Effect of Recombinant Human Brain Natriuretic Peptide on Early Renal Injury in Patients with Acute Heart Failure[J].Journal of Medical Information,2018,31(11):73-75.[doi:10.3969/j.issn.1006-1959.2018.11.023]
点击复制

重组人脑利钠肽对急性心力衰竭早期肾损伤的疗效研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年11期
页码:
73-75
栏目:
论著
出版日期:
2018-06-01

文章信息/Info

Title:
Therapeutic Effect of Recombinant Human Brain Natriuretic Peptide on Early Renal Injury in Patients with Acute Heart Failure
文章编号:
1006-1959（2018）11-0073-03
作者:
李 军; 王 淼; 李 伟; 蒋海森; 王义围
承德医学院附属医院全科医疗科，河北 承德 067000
Author(s):
LI Jun; WANG Miao; LI Wei; JIANG Hai-sen; WANG Yi-wei
Department of General Surgery,Affiliated Hospital of Chengde Medical College,Chengde 067000,Hebei,China
关键词:
rh-BNP; 急性心力衰竭; 早期肾损伤; NAGL; KIM-1
Keywords:
Key words：rh-BNP; Acute heart failure; Early renal injury; NAGL; KIM-1
分类号:
R541.6
DOI:
10.3969/j.issn.1006-1959.2018.11.023
文献标志码:
A
摘要:
目的 运用血清及尿液中性粒细胞明胶酶相关脂质运载蛋白（NAGL）、肾损伤因子-1（KIM-1）评估重组人脑利钠肽（rh-BNP）对住院急性心力衰竭患者早期肾损伤的临床疗效。方法 从我院2016年6月~2017年6月住院急性心力衰竭患者中选取SCr正常、血清及尿液NAGL、KIM-1同时升高者200例，随机分为rhBNP治疗组及常规治疗组，治疗组106例，常规组94例，同时治疗1周，于治疗结束时、结束后1周分别检测两组血清及尿液NGAL、KIM-1水平，并与治疗前比较。结果 治疗结束时两组血清NAG[（409.42±18.24）ng/ml vs（359.68±19.02）ng/ml]、尿液NAGL[（52.29±7.41）ng/ml vs （44.78±11.25）ng/ml]、血清KIM-1[（169.72±74.46）ng/ml vs （144.03±66.95）ng/ml]、尿液KIM-1[（7.39±2.96）ng/ml vs （6.38±3.01）ng/ml]水平均较治疗前下降，差异有统计学意义（P＜0.05）；治疗结束后1周两组血清NAGL[（343.72±16.45）ng/ml vs （321.04±17.34）ng/ml]、尿液NAGL[（30.89±7.94）ng/ml vs （21.01±8.49）ng/ml]、血清KIM-1[（133.32±64.09）ng/ml vs （109.60±45.29）ng/ml]、尿液KIM-1[（5.78±3.03）ng/ml vs （4.50±2.27）ng/ml]水平均较治疗前下降，差异有统计学意义（P＜0.05）。结论 rhBNP对于住院急性心力衰竭患者早期肾损伤有治疗价值。
Abstract:
Abstract：Objective To evaluate the clinical effect of recombinant human brain natriuretic peptide(rh-BNP)on early renal injury in patients with acute heart failure by using serum and urine neutrophil gelatinase related lipid carrier protein(NAGL)and renal injury factor -1(KIM-1).Methods From June 2016 to June 2017 in our hospital,patients with acute heart failure selected 200 patients with normal SCr,serum and urine NAGL and KIM-1,and were randomly divided into rhBNP treatment group and conventional treatment group.106 patients in the treatment group and 94 patients in the conventional group were treated for the same treatment for 1 week. Serum and urine levels of NGAL and KIM-1 were measured at the end of treatment and one week after treatment,respectively,and compared with those before treatment.Results At the end of treatment,serum NAGL[(409.42±18.24)ng/ml vs (359.68±19.02)ng/ml],urine NAGL [(52.29±7.41)ng/ml vs (44.78±11.25)ng/ml],serum KIM-1[(169.72±74.46)ng/ml vs (144.03±66.95)ng/ml],the levels of KIM-1 in urine[(7.39±2.96)ng/ml vs (6.38±3.01)ng/ml]were significantly lower than those before treatment,the difference was statistically significant(P<0.05);One week after treatment,serum NAGL [(343.72±16.45)ng/ml vs (321.04±17.34)],urine NAGL[(30.89±7.94)ng/ml vs (21.01±8.49)ng/ml],serum KIM-1[(133.32±64.09)ng/ml vs (109.60±45.29)ng/ml],the level of urinary KIM-1[(5.78±3.03)ng/ml vs (4.50±2.27)ng/ml]decreased compared with that before treatment,and the difference was statistically significant (P<0.05).Conclusion rhBNP has therapeutic value for early renal injury in hospitalized patients with acute heart failure.

参考文献/References:

[1]Yang CH,Chang CH,Chen TH,et al.Combination of urinary biomarkers improves early detection of acute kidney injury in patients with heart failure[J].Circ J,2016,80(4):1017-1023. [2]Bouquegneau A,Krzesinski JM,Delanaye P,et al.Biomarkers and physiopathology in the cardiorenal syndrome[J].Clin Chim Acta,2015,443:100-107. [3]Klimenko A,Villevalde S,Kobalava Z.Urine NGAL and KIM-1 predicts poor outcomes in patients with acute kidney injury and decompensated heart failure[J].Nephrology Dialysis Transplantation,2014,29(3):110. [4]Jungbauer C,Stadler S,Birner C,et al.Activation pattern of novel renal biomarkers in acute heart failure:Superiority of NGAL[J].European Heart Journal,2014,35:862. [5]Molina M,Ticehurst E,Claridge T,et al.Nesiritide use in adult heart transplant recipients with early acute kidney injury:6 month follow-up[J].American Journal of Transplantation,2013,13:452. [6]Palazzuoli A,Ruocco G,Pellegrini M,et al.Comparison of neutrophil gelatinase-associated lipocalin versus B-type natriuretic peptide and cystatin C to predict early acute kidney injury and outcome in patients with acute heart failure[J].Am J Cardiol,2015,116(1):104-111. [7]Alvelos M,Lourenco P,Dias C,et al.Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure[J].Int J Cardiol,2013,165(1):51-55. [8]Klimenko A,Villevalde S,Kobalava Z.Biomarkers as determinants of poor outcomes in patients with acute kidney injury and decompensated heart failure[J].European Heart Journal:Acute Cardiovascular Care,2016,15:130-131. [9]Sokolski Mateusz,Zymliński Robert,Biegus Jan,et al.Novel urinary kidney biomarkers predict worsening renal function in patients with acute heart failure[J].Kardiologia Polska,2015,73:316-317. [10]袁方,刘华,王雯霞,等.急性失代偿性心力衰竭合并急性肾损伤的早期诊断研究[J].上海交通大学学报(医学版),2014,12(34):1771-1774.

相似文献/References:

[1]花国辉.冻干重组人脑利钠肽与米力农治疗急性心力衰竭的疗效[J].医学信息,2020,33(03):138.[doi:10.3969/j.issn.1006-1959.2020.03.043]
　HUA Guo-hui.Efficacy of Freeze-dried Recombinant Human Brain Natriuretic Peptide and Milrinone in Treating Acute Heart Failure[J].Journal of Medical Information,2020,33(11):138.[doi:10.3969/j.issn.1006-1959.2020.03.043]
[2]宋予苹,魏 来,陈 斌.BiPAP联合rhBNP在重症AHF抢救治疗中的应用[J].医学信息,2020,33(07):152.[doi:10.3969/j.issn.1006-1959.2020.07.049]
　SONG Yu-ping,WEI Lai,CHEN Bin.Application of BiPAP Combined with rhBNP in Rescue Treatment of Severe AHF[J].Journal of Medical Information,2020,33(11):152.[doi:10.3969/j.issn.1006-1959.2020.07.049]
[3]柯小云,申艳林,余 斐,等.心衰早期预警联合SBAR模式在冠心病心衰患者中的应用效果研究[J].医学信息,2022,35(24):186.[doi:10.3969/j.issn.1006-1959.2022.24.042]
　KE Xiao-yun,SHEN Yan-lin,YU Fei,et al.Study on the Application Effect of Early Warning of Heart Failure Combined with SBAR Mode in Patients with Coronary Heart Disease and Heart Failure[J].Journal of Medical Information,2022,35(11):186.[doi:10.3969/j.issn.1006-1959.2022.24.042]
[4]郑国盛.多巴胺联合硝普钠治疗急性心力衰竭伴低血压的临床效果及对心功能和预后的影响[J].医学信息,2023,36(14):137.[doi:10.3969/j.issn.1006-1959.2023.14.028]
　ZHENG Guo-sheng.Clinical Effect of Dopamine Combined with Sodium Nitroprusside in the Treatment of Acute Heart Failure with Hypotension and its Effect on Cardiac Function and Prognosis[J].Journal of Medical Information,2023,36(11):137.[doi:10.3969/j.issn.1006-1959.2023.14.028]
[5]胡言飞,张长敏.2015-2019年山东省某三甲医院抢救室六大病种流行病学分析[J].医学信息,2023,36(17):45.[doi:10.3969/j.issn.1006-1959.2023.17.008]
　HU Yan-fei,ZHANG Chang-min.Epidemiological Analysis of Six Kinds of Diseases in the Emergency Department of a Tertiary Hospital in Shandong Province from 2015 to 2019[J].Journal of Medical Information,2023,36(11):45.[doi:10.3969/j.issn.1006-1959.2023.17.008]

更新日期/Last Update: 2018-06-01